139 related articles for article (PubMed ID: 37596908)
1. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
3. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
4. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
7. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
8. Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.
Al-Qassabi AM; Al-Farsi F
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):413-416. PubMed ID: 36072081
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
10. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
Vania R; Pranata R; Tan ST
J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
[TBL] [Abstract][Full Text] [Related]
11. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.
Kansal NK
Dermatol Ther; 2020 Nov; 33(6):e13987. PubMed ID: 32638481
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of therapeutic response in warts to intralesional vitamin D3 versus intralesional measles, mumps, and rubella vaccine.
Singh AK; Devi KN; Bist JS
Dermatol Ther; 2022 Nov; 35(11):e15813. PubMed ID: 36088627
[TBL] [Abstract][Full Text] [Related]
15. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
Eldahshan RM; Ashry WMO; Elsaie ML
J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
[TBL] [Abstract][Full Text] [Related]
16. Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases.
Al-Qassabi AM; Al Kindi A
Oman Med J; 2022 Mar; 37(2):e353. PubMed ID: 35356369
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
18. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
Horn TD; Johnson SM; Helm RM; Roberson PK
Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
[TBL] [Abstract][Full Text] [Related]
19. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts.
Na CH; Choi H; Song SH; Kim MS; Shin BS
Clin Exp Dermatol; 2014 Jul; 39(5):583-9. PubMed ID: 24934912
[TBL] [Abstract][Full Text] [Related]
20. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]